Our data showing low quantities of SMN protein in serum-derived exosomes isolated from a mouse model of SMA, with carrier and wildtype mice showing correspondingly higher levels of the protein, suggest that this may serve as a useful biomarker for disease status in SMA. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.